DCE MONTHLY JOURNAL REVIEW
Did you know you can get the articles listed in the Journal Review?
Interested in getting other articles?
DCE Journal Review March 2017
1. Impact of weight maintenance and loss on diabetes risk and burden: a population-based study in 33,184 participants.
2. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.
3. Maintenance of Weight Loss After Initiation of Nutrition Training: A Randomized Trial.
4. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomized, double-blind trial.
5. Total and subtypes of dietary fat intake and risk of type 2 diabetes mellitus in the Prevención con Dieta Mediterránea (PREDIMED) study.
Type I Diabetes:
1. Comparison of Insulin Glargine 300 U/mL and 100 U/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections
2. Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study
3. Impact of type 1 diabetes mellitus and celiac disease on nutrition and quality of life.
4. Stepwise reprogramming of liver cells to a pancreas progenitor state by the transcriptional regulator Tgif2.
5. Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
Type II Diabetes:
1. Differential effects of metformin on age related comorbidities in older men with type 2 diabetes.
2. The number of microvascular complications is associated with an increased risk for severity of periodontitis in type 2 diabetic patients: Results of a multicenter hospital-based cross-sectional study.
3. Novel oral glucose-lowering drugs compared to insulin are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycemia in type 2 diabetes patients.
4. Long-term Metformin Therapy and Monitoring for Vitamin B12 Deficiency Among Older Veterans.
5. Five-Year Outcomes of a Randomized Trial of Gastric Band Surgery in Overweight but Not Obese People With Type 2 Diabetes.
1. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
2. Pediatric Obesity—Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.
3. Discrepancies in Communication Versus Documentation of Weight-Management Benchmarks: Analysis of Recorded Visits With Latino Children and Associated Health-Record Documentation
4. Longitudinal Associations Between Ambient Air Pollution with Insulin Sensitivity, β-Cell Function, and Adiposity in Los Angeles Latino Children.
5. Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development
1. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012.
2. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012.
3. Association Between Duration of Breast Feeding and Metabolic Syndrome: The Korean National Health and Nutrition Examination Surveys.
1. Early post-operative psychosocial and weight predictors of later outcome in bariatric surgery: a systematic literature review.
2. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease.
3. Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death
4. The association between cytomegalovirus infection, obesity, and metabolic syndrome in U.S. adult females.
5. Obesity and cortisol: New perspectives on an old theme.
1. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.
2. An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.
3. Diabetic Neuropathy: A Position Statement by the American Diabetes Association.
4. Periodontitis as a possible early sign of diabetes mellitus.
5. No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase 4 inhibitors versus therapeutic alternatives.